Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyophilized Human Rabies Vaccine (Vero Cell) 4-dose vs 5-dose Regimen Immunity Persistence Study
CTR20222229Phase 3Completed
- Sponsor
- Simcere Vike Biopharmaceutical
- Start
- Sep 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rabies vaccine (Vero cells) in rabies, sponsored by Simcere Vike Biopharmaceutical. Started Sep 2022; status: completed.
02
Drugs
rabies vaccine (Vero cells)
03
Conditions
rabies
Beyond the preview
Go deeper on CTR20222229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222229.